Mon, Oct 20, 2014, 2:11 PM EDT - U.S. Markets close in 1 hr 49 mins

Recent

% | $
Quotes you view appear here for quick access.

TearLab Corporation Message Board

  • dr.cash_money dr.cash_money May 10, 2013 11:24 AM Flag

    Average Analyst Estimate For This Quarter Is $2.18 Mil. Period.

    $2.18 Mil which would be an increase of over 400% from prior year first quarter results. If they are anywhere close to that ... it would be unbelievable growth!!
    Don't put any belief into any other numbers being talked about. Shorts just playing their stupid games again.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • All about GROWTH shorty. Up 400% year over year. Rollout of product just starting. YEARS of similar growth ahead. New short number : 5,444,576!! Longs are not selling. Good luck trying to cover. LOL.

    • Wow. A whole $2 million of revenue and losing about that number. Impressive if you were a small landscaping company. Not impressive if you have a market cap of $230 million.

      • 1 Reply to timman395
      • from a little wrag called the WALL STREET JOURNAL this week. "The most intriguing stock in my space at the moment would be TearLab Corporation (TEAR). TearLab has a first-of-its-kind point-of-care diagnostic platform in ophthalmology designed to diagnose dry-eye disease, which impacts approximately 30 million Americans. In my view, they have the "Holy Grail" in market positioning with regulatory approvals already secured, reimbursement largely in place, a massive potential market, and essentially no competition. The company is still relatively undiscovered by investors and is early in their roll-out."

        You think you're smart and the market is dumb. I think you're about to get another lesson in humility here shorty. A very painful one.

 
TEAR
3.21+0.09(+2.88%)2:09 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.